90 related articles for article (PubMed ID: 31993937)
1. SCD1 activity promotes cell migration via a PLD-mTOR pathway in the MDA-MB-231 triple-negative breast cancer cell line.
Lingrand M; Lalonde S; Jutras-Carignan A; Bergeron KF; Rassart E; Mounier C
Breast Cancer; 2020 Jul; 27(4):594-606. PubMed ID: 31993937
[TBL] [Abstract][Full Text] [Related]
2. Oleate Promotes Triple-Negative Breast Cancer Cell Migration by Enhancing Filopodia Formation through a PLD/Cdc42-Dependent Pathway.
Guo Z; Bergeron KF; Mounier C
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612766
[TBL] [Abstract][Full Text] [Related]
3. HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple‑negative breast cancer metastasis via the inhibition of CXCR4 expression.
Takeda T; Tsubaki M; Genno S; Tokunaga K; Tanaka R; Nishida S
Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37477145
[TBL] [Abstract][Full Text] [Related]
4. Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN.
Ran H; Zhu Y; Deng R; Zhang Q; Liu X; Feng M; Zhong J; Lin S; Tong X; Su Q
J Exp Clin Cancer Res; 2018 Mar; 37(1):54. PubMed ID: 29530061
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.
Tsai YF; Huang CC; Lin YS; Hsu CY; Huang CP; Liu CY; Chiu JH; Tseng LM
Cancer Immunol Immunother; 2021 Aug; 70(8):2339-2351. PubMed ID: 33512556
[TBL] [Abstract][Full Text] [Related]
6. Xianlinglianxiafang Inhibited the growth and metastasis of triple-negative breast cancer via activating PPARγ/AMPK signaling pathway.
Yang X; Yang R; Zhang Y; Shi Y; Ma M; Li F; Xie Y; Han X; Liu S
Biomed Pharmacother; 2023 Sep; 165():115164. PubMed ID: 37478577
[TBL] [Abstract][Full Text] [Related]
7. Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.
Ou X; Tan Y; Xie J; Yuan J; Deng X; Shao R; Song C; Cao X; Xie X; He R; Li Y; Tang H
Drug Resist Updat; 2024 Mar; 73():101063. PubMed ID: 38335844
[TBL] [Abstract][Full Text] [Related]
8. Cell morphology best predicts tumorigenicity and metastasis in vivo across multiple TNBC cell lines of different metastatic potential.
Conner SJ; Guarin JR; Le TT; Fatherree JP; Kelley C; Payne SL; Parker SR; Bloomer H; Zhang C; Salhany K; McGinn RA; Henrich E; Yui A; Srinivasan D; Borges H; Oudin MJ
Breast Cancer Res; 2024 Mar; 26(1):43. PubMed ID: 38468326
[TBL] [Abstract][Full Text] [Related]
9. Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells.
Lee J; Jang S; Im J; Han Y; Kim S; Jo H; Wang W; Cho U; Kim SI; Seol A; Kim B; Song YS
J Ovarian Res; 2024 Apr; 17(1):73. PubMed ID: 38566208
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicle-Mediated Purinergic Signaling Contributes to Host Microenvironment Plasticity and Metastasis in Triple Negative Breast Cancer.
Duan S; Nordmeier S; Byrnes AE; Buxton ILO
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435297
[TBL] [Abstract][Full Text] [Related]
11. Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer.
Tan Z; Deme P; Boyapati K; Claes BSR; Duivenvoorden AAM; Heeren RMA; Tressler CM; Haughey NJ; Glunde K
Breast Cancer Res; 2023 Nov; 25(1):148. PubMed ID: 38017485
[TBL] [Abstract][Full Text] [Related]
12. SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine model.
Bellenghi M; Talarico G; Botti L; Puglisi R; Tabolacci C; Portararo P; Piva A; Pontecorvi G; Carè A; Colombo MP; Mattia G; Sangaletti S
Oncogene; 2022 Aug; 41(34):4055-4065. PubMed ID: 35851846
[TBL] [Abstract][Full Text] [Related]
13. SCD1 inhibition enhances the effector functions of CD8
Sugi T; Katoh Y; Ikeda T; Seta D; Iwata T; Nishio H; Sugawara M; Kato D; Katoh K; Kawana K; Yaguchi T; Kawakami Y; Hirai S
Cancer Sci; 2024 Jan; 115(1):48-58. PubMed ID: 37879607
[TBL] [Abstract][Full Text] [Related]
14. [Expression of SCD1 in TFE3-rRCC and its effect on proliferation and migration].
Dong YH; Liuxu WT; Chen Y; Gan WD; Li DM
Zhonghua Nan Ke Xue; 2023 Aug; 29(8):682-687. PubMed ID: 38619513
[TBL] [Abstract][Full Text] [Related]
15. Sapienic Acid Metabolism Influences Membrane Plasticity and Protein Signaling in Breast Cancer Cell Lines.
Küçüksayan E; Sansone A; Chatgilialoglu C; Ozben T; Tekeli D; Talibova G; Ferreri C
Cells; 2022 Jan; 11(2):. PubMed ID: 35053341
[TBL] [Abstract][Full Text] [Related]
16. Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells.
Ohya Y; Ogiso Y; Matsuda M; Sakae H; Nishida K; Miki Y; Fox TE; Kester M; Sakamoto W; Nabe T; Kitatani K
Cells; 2024 Feb; 13(5):. PubMed ID: 38474369
[TBL] [Abstract][Full Text] [Related]
17. 3-D chromatin conformation, accessibility, and gene expression profiling of triple-negative breast cancer.
Llinàs-Arias P; Ensenyat-Méndez M; Orozco JIJ; Íñiguez-Muñoz S; Valdez B; Wang C; Mezger A; Choi E; Tran YZ; Yao L; Bonath F; Olsen RA; Ormestad M; Esteller M; Lupien M; Marzese DM
BMC Genom Data; 2023 Nov; 24(1):61. PubMed ID: 37919672
[TBL] [Abstract][Full Text] [Related]
18. New Insights into the Role of Exercise in Inhibiting mTOR Signaling in Triple-Negative Breast Cancer.
Agostini D; Natalucci V; Baldelli G; De Santi M; Donati Zeppa S; Vallorani L; Annibalini G; Lucertini F; Federici A; Izzo R; Stocchi V; Barbieri E
Oxid Med Cell Longev; 2018; 2018():5896786. PubMed ID: 30363988
[TBL] [Abstract][Full Text] [Related]
19. CXCL9 influences the tumor immune microenvironment by stimulating JAK/STAT pathway in triple-negative breast cancer.
Wu L; Sun S; Qu F; Sun M; Liu X; Sun Q; Cheng L; Zheng Y; Su G
Cancer Immunol Immunother; 2023 Jun; 72(6):1479-1492. PubMed ID: 36472587
[TBL] [Abstract][Full Text] [Related]
20. Exercise mitigates flow recirculation and activates metabolic transducer SCD1 to catalyze vascular protective metabolites.
Cavallero S; Roustaei M; Satta S; Cho JM; Phan H; Baek KI; Blázquez-Medela AM; Gonzalez-Ramos S; Vu K; Park SK; Yokota T; Sumner J; Mack JJ; Sigmund CD; Reddy ST; Li R; Hsiai TK
Sci Adv; 2024 Feb; 10(7):eadj7481. PubMed ID: 38354249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
